Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3).

Trial Profile

Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 Oct 2012

At a glance

  • Drugs Testosterone (Primary) ; Acyline; Chorionic gonadotropin
  • Indications Hypogonadism; Male infertility
  • Focus Pharmacodynamics
  • Acronyms HOP-3
  • Most Recent Events

    • 30 Dec 2010 Actual initiation date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 30 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top